✦ LIBER ✦

Current Role of Metaiodobenzylguanidine in the Diagnosis of Pheochromocytoma and Medullary Thyroid Cancer

✍ Scribed by Ioannis Ilias; Chaitanya Divgi; Karel Pacak

Book ID: 117822471
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 758 KB
Volume: 41
Category: Article
ISSN: 0001-2998
DOI: 10.1053/j.semnuclmed.2011.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted Systemic Radiotherapy of Pheoch

Targeted Systemic Radiotherapy of Pheochromocytoma and Medullary Thyroid Cancer

✍ Chaitanya Divgi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Genetics, Diagnosis, and Management of M

Genetics, Diagnosis, and Management of Medullary Thyroid Carcinoma and Pheochromocytoma/Paraganglioma

✍ Moraitis, Andreas; Martucci, Victoria; Pacak, Karel 📂 Article 📅 2014 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 832 KB

Diagnosis and treatment of medullary thy

Diagnosis and treatment of medullary thyroid cancer

✍ Elisabeth Modigliani; Brigitte Franc; Patricia Niccoli-sire 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Medullary thyroid cancer: the role of ra

Medullary thyroid cancer: the role of radiotherapy in local control

✍ K.M. Fife; M. Bower; C.L. Harmer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 363 KB

The role of radiotherapy in the manageme

The role of radiotherapy in the management of medullary thyroid cancer

✍ Larry D. Greenfield; Frederick W. George III 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Absence of TP53 alterations in pheochrom

Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas

✍ Klaus K.-F. Herfarth; Mark R. Wick; Helen N. Marshall; Elaina Gartner; Sharon Lu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

The role of the TP53 gene in the development of inherited and sporadic pheochromocytomas and medullary thyroid carcinomas (MTC) has not been clarified because of conflicting reports and limitations in the assays used to detect mutations. To determine the frequency of TP53 alterations in these tumors